The global vaginal rejuvenation market size was estimated at USD 3.57 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 22.07% from 2024 to 2030. Changing women’s lifestyles and growing awareness of the associated therapy or surgery are expected to drive the vaginal rejuvenation market over the forecast period. In addition, growing awareness of cosmetic procedures, especially female aesthetic genital surgery is anticipated to fuel the market in the future. The outbreak of COVID-19 led many aesthetic facilities to completely halt their services and permanently cancel appointments as they were considered non-essential and high contact in nature. Surgical aesthetic treatments like vaginal rejuvenation also witnessed a setback and the number of procedures declined due to the pandemic.
The increasing popularity of radiofrequency-based treatments is also driving the vaginal rejuvenation market. Radiofrequency-based devices, such as Viveve and Geneveve are gaining popularity owing to their non-invasive and safe single-session result nature, respectively. Viveve delivers volumetric radiofrequency of (90J/cm²) 3-5mm in vaginal tissue, which improves the blood circulation, whereas the 30-minute session by Geneveve treatment has improved the health and quality lives of thousands of women worldwide. Moreover, the treatment is proved effective for dryness due to childbirth and loss of vaginal elasticity.
Urinary incontinence, pelvic organ prolapse, overactive bladder syndrome, and fecal incontinence are some of the disorders prevalent in the U.S. Approximately 24% of women are suffering from one of the following conditions in the U.S.A. Precisely, 16% of women are suffering from urinary incontinence, 9% of women are affected by fecal incontinence, and 3% of women with pelvic organ prolapse. This number is anticipated to rise from 28.1 million (2010) to 43.8 million (2050). Hence, rising cases of uterine prolapse, birthing injuries, and urinary incontinence in women due to growing life expectancy are expected to drive the market.
Surging demand for energy-based treatments is also anticipated to fuel the vaginal rejuvenation market in the forthcoming years. Energy-based devices for the targeted surgery use either thermal or non-thermal energy for different layers of the vaginal tissue. This stimulates the regeneration of collagen, toughens the elastic fibers, helps neovascularization, and recovers vaginal lubrication.
Moreover, the growing success rate of radiofrequency and laser technologies in improving tissue properties, dermatology, and aesthetic medicine is affecting the growth of the vaginal rejuvenation market. The application of these technologies in vaginal rejuvenation has significantly expanded therapeutic indications in various biological tissue-related issues. Hence, devices incorporated with these technologies help women relish, reclaim, and improve their femininity to the fullest.
The pandemic affected the global aesthetic industry especially invasive cosmetic surgeries as the government in many countries mandated temporary shutdowns of aesthetic facilities. The third and fourth quarters of 2020 witnessed ease in lockdowns and many plastic surgeons and aesthetic centers started taking in appointments and consultations but with strict guidelines and limited patients per day. The number of labiaplasty procedures carried out globally decreased by 13% in 2020 as compared to 2019, according to the International Society of Aesthetic Plastic Surgery. However, the market is expected to recover from the effect of the pandemic, as the American Society of Plastic Surgeons stated, there is pent-up patient demand for invasive as well as non-invasive treatments post-pandemic.
The cosmetic vaginal rejuvenation segment held the largest market share of 66.0% in 2023 of the market. By treatment type, the vaginal rejuvenation market is divided into reconstructive vaginal rejuvenation and cosmetic vaginal rejuvenation. Reconstructive vaginal rejuvenation is further sub-segmented as perineoplasty and vaginoplasty. Cosmetic vaginal rejuvenation is also categorized as G-spot amplification, labioplasty, hymenoplasty, and hoodectomy. The cosmetic vaginal rejuvenation segment held a larger share of the market in 2023 owing to the increasing demand for surgeries, such as vaginoplasty, labia majoraplasty, monsplasty, clitoral hood reduction, and labiaplasty.
Amongst these, Labiaplasty is most commonly performed surgery due to an increasing number of issues related to the genital area. According to the American Society for Aesthetic Plastic Surgery (ASAPS), approximately 12, 756 surgeries were executed in 2018, with one surgery charging more than $53 million. ASAPS also predicts a 53% increase in the number of labiaplasty in the last 5 years.
The reconstructive vaginal rejuvenation segment is anticipated to grow at a significant rate over the forecast period owing to the growing number of patients reporting progression in prolapse, decreased vaginal sensation regarding vaginal wall laxity, and sexual dysfunction. Reconstructive vaginal rejuvenation is focused on repairing and correcting the structure of the vagina, especially after C-section delivery. This helps women to continue their lifestyle without complications or pain in urination, intercourse, and menstruation.
The surgical segment held the largest market share of 54.0% in 2023 of the market. By type, the market is divided into surgical and non-surgical. Non-surgical vaginal rejuvenation is further sub-segmented as laser, RF technologies, HIFU, and fillers. Labiaplasty accounts for the largest share of surgical type. Labiaplasty is a surgical procedure that involves reshaping or reducing the size of the labia minora (the inner folds of the vulva) or the labia majora (the outer folds). Women opt for labiaplasty for aesthetic reasons, to address discomfort caused by enlarged labia, or to improve the overall appearance of the genital area. The growing insurance coverage of labiaplasty in Western countries is expected to positively impact the market.
Nonsurgical vaginal rejuvenation, on the other hand, has a number of advantages, including being a less invasive choice for women looking to improve their personal wellbeing. One significant advantage is the lack of downtime, which allows people to resume normal activities immediately following the treatment. Nonsurgical rejuvenation therapies, including as laser therapy or radiofrequency treatments, are faster, more efficient, and less painful than surgical alternatives. Because of the aforementioned benefits, the segment is expected to grow rapidly.
The aging and childbirth segment held the largest market share of 43.9% in 2023 of the market. By application, the market is divided into incontinence, aging and childbirth, aesthetic purposes, and others. Physical changes in the female genitalia occur as a result of ageing and childbirth. Stretching of the vaginal tissues occurs during pregnancy and childbirth, and hormonal changes linked with ageing can contribute to concerns such as decreased elasticity, dryness, and changes in tissue tone. The rising trend of combining vaginal birth with vaginal tightening operations is projected to fuel market expansion. According to a PMC PubMed publication published in January 2020, vaginal birth with vaginal tightening surgery was determined to be a safe and successful approach.
The vaginal rejuvenation procedure also involves reshaping or reducing the size of the labia (the folds of skin surrounding the vulva) for aesthetic concerns. Moreover, women seek labiaplasty for cosmetic reasons, such as to address concerns about the appearance of enlarged or asymmetrical labia. Surgeons have practiced surgical labiaplasty for decades, establishing the procedure as a safe & effective outpatient procedure. The growing concern towards appearance is likely to drive the aesthetic segment.
The 30-40 segment accounted for the major share of 42.3% in 2023 of the market. By age category, the market is divided into below 20/20-30, 30-40, and 40 and above. Women between the ages of 30 and 40 are the most common clients for vaginal rejuvenation procedures worldwide. Pregnancy and childbirth loosen and weaken the interior tissue of the vagina in this age range. As the exterior vulva tissue expands, a syndrome known as Vaginal Relaxation Syndrome develops. Furthermore, when collagen production declines over time, the vaginal wall becomes dry and thin. Mild prolapse, urine incontinence, and perineal scarring are also symptoms of the illness.
However, the demand for vaginal rejuvenation is increasing in the 20-30 age range due to a variety of causes such as changing lifestyle and increased awareness of surgical and nonsurgical vaginal rejuvenation procedures. Furthermore, social media impact is playing an essential part in the market's growth in the 20-30 age group segment.
The Asia Pacific market dominated the market with a revenue share of 28.9% in 2023 and is anticipated to grow at the highest CAGR of 23.11% during the forecast period. Rising awareness about vaginal rejuvenation in Japan, China, South Korea, India, & other south-east nations and low cost of surgeries are some of the key factors driving market growth. Moreover, the increasing adoption of noninvasive gynecological procedures is expected to improve the demand for vaginal rejuvenation.
North America registered a significant share of the market in 2023 owing to the increasing number of vaginal procedures and the high disposable income of consumers. The demand for labiaplasty surgery grew more than 24% in 2019. Moreover, the surgery offered 90% satisfaction among its patients. Owing to this factor, vaginal rejuvenation surgery is anticipated to be one of the common trends in 2023.
The players in the global market include Candela Corporation, Alma Lasers, Lutronic, Fotona, Viveve, BTL Group of Companies, VenusConcept, and Hironic. These players are adopting growth strategies, such as mergers and acquisitions, new product launches, development in the existing strategies, expansion of product portfolio, and more.
vConfidence is one of the leading players in the industry that offers modernized RF and laser technologies to cure women’s vaginal health. They have launched devices, such as Intima, FemiLift, Viveve Geneveve, and FemTouch.
When combined with other treatment protocols, these devices offer consistent and non-invasive results. In a single session of 5-minute treatment, the patients can resume their daily activities immediately. The treatment helps tighten the vaginal tunnel, improve menopausal dryness, balance pH, and improve thinning vaginal walls. The use of energy-based techniques, such as minimally ablative fractional laser and radiofrequency, for the treatment of vaginal laxity, orgasmic dysfunction, and stress incontinence is gaining traction.
Report Attribute |
Details |
Market size value in 2024 |
USD 4.33 billion |
Revenue forecast in 2030 |
USD 14.34 billion |
Growth rate |
CAGR of 22.07% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Report updated |
December 2023 |
Quantitative units |
Revenue in USD million/billion, and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Treatment type, type, application, age category, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; Germany; U.K.; France; Italy; Spain; Sweden; Denmark; Norway; China; Japan; India; Thailand; Korea; Australia; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
Candela Corporation; Alma Lasers; Lutronic; Fotona; Viveve; BTL Group of Companies; VenusConcept; Hironic; Cynosure; Lumenis |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global vaginal rejuvenation market report on the basis of treatment type, type, application, age category, and region:
Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
Reconstructive Vaginal Rejuvenation
Perineoplasty
Vaginoplasty
Cosmetic Vaginal Rejuvenation
G-spot Amplification
Labioplasty
Hymenoplasty
Hoodectomy
Type Outlook (Revenue, USD Million, 2018 - 2030)
Surgical
Non-surgical
Application Outlook (Revenue, USD Million, 2018 - 2030)
Incontinence
Aesthetic Purposes
Aging And Childbirth
Others
Age Category Outlook (Revenue, USD Million, 2018 - 2030)
Below 20/ 20-30
30-40
40 And Above
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Sweden
Denmark
Norway
Asia Pacific
Japan
China
India
Korea
Thailand
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. The global vaginal rejuvenation market size was estimated at USD 3.57 billion in 2023 and is expected to reach USD 4.33 billion in 2024.
b. The global vaginal rejuvenation market is expected to grow at a compound annual growth rate of 22.07% from 2024 to 2030 to reach USD 14.34 billion by 2030.
b. The cosmetic vaginal rejuvenation segment dominated the vaginal rejuvenation market with a share of 66.0% in 2023. This is attributable to the growing demand for vaginal surgeries, especially in developed countries.
b. Some key players operating in the vaginal rejuvenation market include Alma Lasers, Lutronic, Candela Corporation, Viveve, BTL Group of Companies, VenusConcept, Fotona, Hironic, Cynosure
b. Key factors that are driving the vaginal rejuvenation market growth include changing lifestyles along with rising disposable income and knowledge about the availability of various treatment options.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."